Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.59 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.57 |
| ▸ | OPRL1 | P41146 | 4/20 | 0.56 |
| ▸ | IL23R | Q5VWK5 | 1/20 | 0.54 |
| ▸ | NPBWR1 | P48145 | 6/20 | 0.54 |
| ▸ | TFPI | P10646 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29770069 | 0.90 | TFPI (0.63) | OPRK1OPRD1IL23RTFPI | |
| Dynorphin B SCHEMBL30589448 | 0.89 | OPRD1 (0.61) | OPRK1OPRD1OPRL1NPBWR1TFPI | |
| Dynorphin B SCHEMBL29374545 | 0.89 | OPRD1 (0.61) | OPRK1OPRD1OPRL1NPBWR1TFPI | |
| SCHEMBL30385132 | 0.86 | TFPI (0.63) | OPRK1OPRD1IL23RTFPI | |
| SCHEMBL29402789 | 0.82 | OPRK1 (0.63) | OPRK1OPRD1IL23RNPBWR1 | |
| SCHEMBL29794241 | 0.82 | GLP1R (0.51) | OPRK1OPRD1 | |
| SCHEMBL29961427 | 0.80 | NPY1R (0.74) | — | |
| SCHEMBL29370080 | 0.80 | NPY1R (0.69) | OPRK1OPRD1NPBWR1 | |
| SCHEMBL30974431 | 0.80 | KISS1R (0.53) | OPRK1OPRD1IL23RTFPI | |
| SCHEMBL29539873 | 0.80 | NPY4R (0.62) | OPRK1OPRD1IL23R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 130 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250345481-A1 | NANOCOMPOSITE HYDROGELS AND RELATED METHODS AND APPLICATIONS | THE CHINESE UNIVERSITY OF HONG KONG (HK) | 2025-11-13 | — | — | US | claimed |
| US-20250213644-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF BONE-RELATED DISEASE OR DISORDER | GABET, Yankel (IL) | 2025-07-03 | — | — | US | claimed |
| CN-119954897-A | Bioconjugate and use thereof | 湖北大学 | 2025-05-09 | — | — | CN | claimed |
| CN-119506989-A | Porous silver antibacterial coating material based on synchronous bimetallic plating and single electrolytic stripping process and preparation method thereof | 浙江大学 | 2025-02-25 | — | — | CN | claimed |
| CN-119479797-A | Multifunctional peptide design method and application thereof | 山东第二医科大学 | 2025-02-18 | — | — | CN | claimed |
| CN-119386249-A | In-situ injectable bone repair adhesive material with dual sequential bone function promotion function and preparation method and application thereof | 浙江大学 | 2025-02-07 | — | — | CN | claimed |
| CN-119215230-A | Injectable photo-curing double-network hydrogel and preparation method and application thereof | 天津市口腔医院(天津市整形外科医院、南开大学口腔医院) | 2024-12-31 | — | — | CN | claimed |
| CN-119033999-A | Composition containing titanium dioxide nanotubes and application of composition in preparation of product for promoting osteoblast bone maturation | 许隽松 | 2024-11-29 | — | — | CN | claimed |
| US-20240307491-A1 | ERYTHROPOIETIN AND FIBRONECTIN COMPOSITIONS FOR BONE REGENERATION | REMEDOR BIOMED LTD. (IL) | 2024-09-19 | — | — | US | claimed |
| US-20240285723-A1 | COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2024-08-29 | — | — | US | claimed |
| CN-113398325-B | Fibrous membrane for enhancing screw stability and inducing bone regeneration and preparation method thereof | 叶川 | 2023-04-21 | — | — | CN | claimed |
| WO-2023026280-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF BONE-RELATED DISEASE OR DISORDER | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-03-02 | — | — | WO | claimed |
| EP-3618881-B1 | POST-3D PRINTING FUNCTIONALIZATION OF POLYMER SCAFFOLDS FOR ENHANCED BIOACTIVITY | UNIV AKRON (US) | 2023-02-15 | — | — | EP | claimed |
| WO-2022269616-A1 | COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2022-12-29 | — | — | WO | claimed |
| CN-113134114-B | Anti-infection coating capable of being constructed immediately in operation and preparation method and application thereof | 中国人民解放军总医院第八医学中心 | 2022-12-02 | — | — | CN | claimed |
| CN-115087662-A | Bispecific fusion polypeptide compounds | 陕西麦科奥特科技有限公司 | 2022-09-20 | — | — | CN | claimed |
| EP-4041278-A1 | ACTIVE POLYPEPTIDE COMPOUND | Shaanxi Micot Technology Limited Company (CN) | 2022-08-17 | — | — | EP | claimed |
| CN-114504685-A | Guide film and preparation method thereof | 无锡领缔生物科技有限公司 | 2022-05-17 | — | — | CN | claimed |
| CN-111420118-B | Titanium-based active bone implant with ROS response and preparation method thereof | 重庆大学 | 2022-05-17 | — | — | CN | claimed |
| WO-2022052471-A1 | BISPECIFIC FUSION POLYPEPTIDE COMPOUND | 陕西麦科奥特科技有限公司 | 2022-03-17 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250213644-A1 | COMPOSITIONS AND METHODS FOR TREATMENT OF BONE-RELATED DISEASE OR DISORDER | BMP2, CALCB, CALCA | OPRK1 750/4885OPRD1 1864/4885OPRL1 979/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.